Urinary Catheter Self-Discontinuation After Urogynecology Surgery
Launched by UNIVERSITY OF TEXAS AT AUSTIN · May 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to find out if patients can safely remove their urinary catheters at home after certain types of surgeries related to pelvic issues, like pelvic organ prolapse and stress urinary incontinence. Currently, catheters are typically taken out in the doctor's office, but this study will compare that method to allowing patients to remove their own catheters at home. The goal is to see if self-removal is just as safe and effective.
To participate, women aged 18 and older who are fluent in English or Spanish and are having specific surgeries that involve a urinary catheter may be eligible. Participants will either remove their catheter at home or have it removed in the office. Those who have certain medical conditions that affect their ability to self-remove the catheter, or who need a catheter for a longer period due to other medical procedures, will not be included in the study. If you join, you can expect a straightforward process with guidance on how to safely manage your catheter removal, contributing to important research that may help many women in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Are at least 18 years of age
- • 2. Are fluent and able to read in English or Spanish
- • 3. Undergo POP and/or SUI surgery (uterosacral ligament suspension, sacrospinous ligament fixation, sacral colpopexy, anterior colporrhaphy, posterior colporrhaphy, and/or mid-urethral sling) that occurs on Monday - Thursday
- • 4. Have transurethral catheter in place at the conclusion of surgery as part of standard care
- • 5. Are diagnosed with POUR on POD0 based on ultrasound bladder scan PVR of 100 mL or more
- • 6. Are discharged home on the same day of surgery (POD 0)
- Exclusion Criteria:
- • 1. Have preoperative voiding dysfunction requiring self-catheterization or indwelling transurethral catheter
- • 2. Have physical or mental impairment that would impact their ability to remove their catheter themselves.
- • 3. Undergo urethral bulking injections as part of surgery
- • 4. Have undergone a planned or unplanned urinary tract procedure requiring prolonged catheterization as standard of care (e.g. cystotomy repair, ureteral reimplantation, vesicovaginal fistula repair, urethral diverticulum repair)
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Round Rock, Texas, United States
Kyle, Texas, United States
Austin, Texas, United States
Patients applied
Trial Officials
Mary M Rieger, MD
Principal Investigator
University of Texas at Austin
Collin M McKenzie, MD
Principal Investigator
University of Texas at Austin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported